Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Goodwin Biotechnology Appoints Darrin Schellin CEO | Contract Pharma
Breaking News, Promotions & Moves

Goodwin Biotechnology Appoints Darrin Schellin CEO

Schellin will also serve as a member of the company's board of directors.

Goodwin Biotechnology, Inc. has appointed Darrin Schellin as Chief Executive Officer and will also serve as a member of the company’s board of directors. Darrin will be based in Florida.
 
Darrin’s career in the life sciences industry spans several decades. After successful supply chain and operations management assignments with Culligan and Bausch & Lomb, he was part of the leadership team at Alliance Medical Products as COO and then CEO, growing the company rapidly over a decade until it was sold to Swiss CDMO, Siegfried Holding AG. Darrin then ran Siegfried’s global drug products business for six years, managing five sites across the U.S. and Europe.
 
Karl Pinto, Executive Chairman, said, “These are exciting times. Darrin’s rich experience within the CDMO space, his successful track record in scaling operations, building excellent teams, and business development make him the ideal person to lead Goodwin at this important point in our evolution. As someone who has led Goodwin over many years to become the preferred manufacturing partner to dozens of biopharmaceutical clients today, I welcome Darrin to Goodwin. His leadership skills, customer-first approach, and strong integrity will add great impetus to Goodwin’s mission and enable us to scale the new heights we have planned for the company. With Darrin’s addition, we will accelerate our ability to bring more hope and life to more patients globally.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters